Allergan, Hi-Tech Settle IP Case Over Generic Combigan
A Texas federal judge approved a settlement Tuesday resolving Allergan Inc.'s patent suit over Hi-Tech Pharmacal Co. Inc.'s bid to market a generic version of Allergan's glaucoma treatment Combigan....To view the full article, register now.
Already a subscriber? Click here to view full article